Browse by Publisher
Browse by Region

Sort By:
Report Status:
189791 Report Results
Page 1 of 7592
Go To Page:
    
  Go

Acute Respiratory Distress Syndrome - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Acute Respiratory Distress Syndrome - Pipeline Review, H1 2017’, provides an overview of the Acute Respiratory Distress Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Acute Respiratory Distress Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The r.....

African Trypanosomiasis - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘African Trypanosomiasis - Pipeline Review, H1 2017’, provides an overview of the African Trypanosomiasis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for African Trypanosomiasis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive ph.....

Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2017’, provides an overview of the Alpha- Antitrypsin Deficiency pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Alpha- Antitrypsin Deficiency, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers .....

Alzheimer's Disease - Pipeline Review, H1 2017

$2,500.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H1 2017’, provides an overview of the Alzheimer's Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Alzheimer's Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacologica.....

Arrhythmias - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Arrhythmias - Pipeline Review, H1 2017’, provides an overview of the Arrhythmias pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Arrhythmias, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeu.....

Atopic Dermatitis - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Atopic Dermatitis - Pipeline Review, H1 2017’, provides an overview of the Atopic Dermatitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Atopic Dermatitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological acti.....

Atrial Fibrillation - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Atrial Fibrillation - Pipeline Review, H1 2017’, provides an overview of the Atrial Fibrillation pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Atrial Fibrillation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacologica.....

Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2017’, provides an overview of the Attention Deficit Hyperactivity Disorder (ADHD) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Attention Deficit Hyperactivity Disorder (ADHD), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administr.....

Bacillary Dysentery (Shigellosis) - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Bacillary Dysentery (Shigellosis) - Pipeline Review, H1 2017’, provides an overview of the Bacillary Dysentery (Shigellosis) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Bacillary Dysentery (Shigellosis), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report .....

Batten Disease - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Batten Disease - Pipeline Review, H1 2017’, provides an overview of the Batten Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Batten Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the.....

Becker Muscular Dystrophy - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Becker Muscular Dystrophy - Pipeline Review, H1 2017’, provides an overview of the Becker Muscular Dystrophy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Becker Muscular Dystrophy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descript.....

Bone Marrow Transplant Rejection - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Bone Marrow Transplant Rejection - Pipeline Review, H1 2017’, provides an overview of the Bone Marrow Transplant Rejection pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Bone Marrow Transplant Rejection, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report als.....

Burns - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Burns - Pipeline Review, H1 2017’, provides an overview of the Burns pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Burns, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete.....

Candidiasis - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Candidiasis - Pipeline Review, H1 2017’, provides an overview of the Candidiasis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Candidiasis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeu.....

Cat Allergy - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Cat Allergy - Pipeline Review, H1 2017’, provides an overview of the Cat Allergy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Cat Allergy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeu.....

Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2017’, provides an overview of the Chemotherapy Induced Nausea and Vomiting pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Chemotherapy Induced Nausea and Vomiting, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molec.....

Chemotherapy Induced Neutropenia - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Chemotherapy Induced Neutropenia - Pipeline Review, H1 2017’, provides an overview of the Chemotherapy Induced Neutropenia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Chemotherapy Induced Neutropenia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report als.....

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H1 2017’, provides an overview of the Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), complete with analysis by stage of development, drug target, mechanism of actio.....

Cluster Headache Syndrome - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Cluster Headache Syndrome - Pipeline Review, H1 2017’, provides an overview of the Cluster Headache Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Cluster Headache Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descript.....

Coccidioidomycosis - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Coccidioidomycosis - Pipeline Review, H1 2017’, provides an overview of the Coccidioidomycosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Coccidioidomycosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological a.....

Complex Regional Pain Syndrome - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Complex Regional Pain Syndrome - Pipeline Review, H1 2017’, provides an overview of the Complex Regional Pain Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Complex Regional Pain Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also cove.....

Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2017’, provides an overview of the Congestive Heart Failure (Heart Failure) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Congestive Heart Failure (Heart Failure), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molec.....

Contrast Induced Nephropathy - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Contrast Induced Nephropathy - Pipeline Review, H1 2017’, provides an overview of the Contrast Induced Nephropathy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Contrast Induced Nephropathy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the.....

Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2017’, provides an overview of the Coronary Artery Disease (CAD) (Ischemic Heart Disease) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Coronary Artery Disease (CAD) (Ischemic Heart Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA.....

Crigler-Najjar Syndrome - Pipeline Review, H1 2017

$2,000.00
By:
, Published: Mar-2017
Global Markets Direct’s, ‘Crigler-Najjar Syndrome - Pipeline Review, H1 2017’, provides an overview of the Crigler-Najjar Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Crigler-Najjar Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive ph.....